|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dekker E, Tanis PJ, Vleugels J, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weiser MR, Landmann RG, Kattan MW, Gonen
M, Shia J, Chou J, Paty PB, Guillem JG, Temple LK, Schrag D, et al:
Individualized prediction of colon cancer recurrence using a
nomogram. J Clin Oncol. 26:380–385. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mercer TR and Mattick JS: Structure and
function of long noncoding RNAs in epigenetic regulation. Nat
Struct Mol Biol. 20:300–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Deniz E and Erman B: Long noncoding RNA
(lincRNA), a new paradigm in gene expression control. Funct Integr
Genomics. 17:135–143. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vance KW and Ponting CP: Transcriptional
regulatory functions of nuclear long noncoding RNAs. Trends Genet.
30:348–355. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi T, Gao G and Cao Y: Long noncoding
RNAs as novel biomarkers have a promising future in cancer
diagnostics. Dis Markers. 2016:90851952016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yildirim E, Kirby JE, Brown DE, Mercier
FE, Sadreyev RI, Scadden DT and Lee JT: Xist RNA is a potent
suppressor of hematologic cancer in mice. Cell. 152:727–742. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He X, Tan X, Wang X, Jin H, Liu L, Ma L,
Yu H and Fan Z: C-Myc-activated long noncoding RNA CCAT1 promotes
colon cancer cell proliferation and invasion. Tumour Biol.
35:12181–12188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu J, Ni G, Mao L, Xue X, Zhang J, Wu W,
Zhang S, Zhao H, Ding L and Wang L: LINC00565 promotes
proliferation and inhibits apoptosis of gastric cancer by targeting
miR-665/AKT3 axis. Onco Targets Ther. 12:7865–7875. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gong M, Luo C, Meng H, Li S, Nie S, Jiang
Y, Wan Y, Li H and Cheng W: Upregulated LINC00565 accelerates
ovarian cancer progression by targeting GAS6. Onco Targets Ther.
12:10011–10022. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Z, Hou P, Fan D, Dong M, Ma M, Li H,
Yao R, Li Y, Wang G, Geng P, et al: The degradation of EZH2
mediated by lncRNA ANCR attenuated the invasion and metastasis of
breast cancer. Cell Death Differ. 24:59–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsang DP and Cheng AS: Epigenetic
regulation of signaling pathways in cancer: Role of the histone
methyltransferase EZH2. J Gastroenterol Hepatol. 26:19–27. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bremer S, Conradi LC, Mechie NC, Amanzada
A, Mavropoulou E, Kitz J, Ghadimi M, Ellenrieder V, Ströbel P,
Hessmann E, et al: Enhancer of zeste homolog 2 in colorectal cancer
development and progression. Digestion. 6:1–9. 2019. View Article : Google Scholar
|
|
18
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cerase A, Smeets D, Tang YA, Gdula M,
Kraus F, Spivakov M, Moindrot B, Leleu M, Tattermusch A, Demmerle
J, et al: Spatial separation of xist RNA and polycomb proteins
revealed by superresolution microscopy. Proc Natl Acad Sci USA.
111:2235–2240. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hashiguchi Y, Hase K, Kotake K, Ueno H,
Shinto E, Mochizuki H, Yamamoto J and Sugihara K: Evaluation of the
seventh edition of the tumour, node, metastasis (TNM)
classification for colon cancer in two nationwide registries of the
United States and Japan. Colorectal Dis. 14:1065–1074. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Okazaki Y, Furuno M, Kasukawa T, Adachi J,
Bono H, Kondo S, Nikaido I, Osato N, Saito R, Suzuki H, et al:
Analysis of the mouse transcriptome based on functional annotation
of 60,770 full-length cDNAs. Nature. 420:563–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie JJ, Li WH, Li X, Ye W and Shao CF:
LncRNA MALAT1 promotes colorectal cancer development by sponging
miR-363-3p to regulate EZH2 expression. J Biol Regul Homeost
Agents. 33:331–343. 2019.PubMed/NCBI
|
|
25
|
Kondo Y, Shen L, Cheng AS, Ahmed S,
Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B,
et al: Gene silencing in cancer by histone H3 lysine 27
trimethylation independent of promoter DNA methylation. Nat Genet.
40:741–750. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mimori K, Ogawa K, Okamoto M, Sudo T,
Inoue H and Mori M: Clinical significance of enhancer of zeste
homolog 2 expression in colorectal cancer cases. Eur J Surg Oncol.
31:376–380. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang CG, Ye YJ, Yuan J, Liu FF, Zhang H
and Wang S: EZH2 and STAT6 expression profiles are correlated with
colorectal cancer stage and prognosis. World J Gastroenterol.
16:2421–2427. 2010. View Article : Google Scholar : PubMed/NCBI
|
